Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.

318.66 6.41 −1.97%
Market cap
$26.4B
P/E
26.2×
Fwd P/E
19.0×
Dividend yield
0.90%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100

Labcorp Holdings Inc. (LH) Total debt

Alert me on Total debt

Labcorp Holdings Inc.'s total debt at the end of fiscal 2025 was $5.1B, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $5.9B. Over the past ten years it has ranged from $4.1B (fiscal 2023) to $6.3B (fiscal 2017); the current reading is higher than 27% of that period. Labcorp Holdings Inc. ranks 4th of 50 Diagnostics & Research companies by total debt.

Total debt, annual

Embed this chart

Annual newest first

Period Total debt Change
FY2025 $5.1B (4.77%)
FY2024 $5.4B 30.78%
FY2023 $4.1B (19.31%)
FY2022 $5.1B (6.88%)
FY2021 $5.5B (0.04%)
FY2020 $5.5B (6.42%)
FY2019 $5.9B (2.66%)
FY2018 $6.0B (4.77%)
FY2017 $6.3B 19.71%
FY2016 $5.3B (10.78%)

Quarterly newest first

Period Total debt Change
Jun 2026 $5.9B 0.40%
Mar 2026 $5.9B 14.54%
Dec 2025 $5.1B 0.02%
Sep 2025 $5.1B 0.08%
42 more quarters

Against its own ten years

Low $4.1B High $6.3B
Ten-year median $5.5B
Current reading's percentile 27

Total debt against peers

What Total debt is

Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.

Long Term Debt (Total) + Current Part of Debt

The full definition of Total debt →

More on LH